Mesenchymal Stem Cells Transplantation for Bronchopulmonary Dysplasia
Scientists monitored the long-term safety and outcomes of intratracheal mesenchymal stem cell application in premature infants with bronchopulmonary dysplasia who were enrolled into the clinical trials. Transplantation appeared to be safe and has no adverse effects were decribed, but there were some benefits associated with this therapy.
http://www.jpeds.com/article/S0022-3476(17)30327-X/abstract?elqTrackId=4d69b3946dc04c748c0d9596edf4ff8b&elq=8d3641dd2d4146f495cbdf944d243f35&elqaid=18629&elqat=1&elqCampaignId=10598
-
18. 04. 2017
MSCs for HBV-Related Acute-on-Chronic Liver Failure
-
10. 04. 2017
Stem cells used to treat erectile dysfunction
-
27. 03. 2017
Mesenchymal stem cells in a murine ovalbumin asthma model
-
20. 03. 2017
Mesenchymal stem cells for lung melanoma metastases therapy
-
13. 03. 2017
Pulp regeneration by transplantation of dental pulp stem cells in pulpitis